The nurse is planning education for a client who has been prescribed an antihypertensive drug. For each nursing education, click to specify whether the education is appropriate or not appropriate.

A. Heart failure: Terazosin is not primarily indicated for heart failure management. While it may have some vasodilatory effects that could theoretically reduce afterload, it is not a standard treatment for heart failure and does not address the core pathophysiology.

B. Peripheral vascular disease: Terazosin does not directly treat peripheral vascular disease. Its mechanism of action as an alpha-1 adrenergic blocker primarily targets vascular smooth muscle to lower systemic blood pressure rather than improve blood flow to peripheral tissues.

C. Pulmonary edema: Pulmonary edema is usually managed with diuretics, oxygen therapy, and addressing the underlying cause. Terazosin does not have an acute role in managing fluid overload or pulmonary congestion.

D. Chronic hypertension: Terazosin is an alpha-1 adrenergic blocker used to treat chronic hypertension by relaxing vascular smooth muscle, reducing peripheral vascular resistance, and lowering blood pressure. It is commonly prescribed for long-term blood pressure control, especially in clients who may also have benign prostatic hyperplasia.

A. A client with an emphysema exacerbation: Clients experiencing an acute exacerbation of emphysema often have increased airway obstruction and difficulty breathing. A small volume nebulizer delivers bronchodilators directly to the lungs, providing rapid relief of bronchospasm and improving oxygenation.

B. A client experiencing an asthma attack: During an asthma attack, airway constriction can be severe. An SVN allows precise delivery of inhaled medications like albuterol, which rapidly dilate the airways and reduce respiratory distress, making it essential for urgent intervention.

C. A client with a common cold and fever: A common cold typically causes mild upper respiratory symptoms such as congestion and runny nose. SVNs are not indicated for routine cold management, as bronchodilator therapy is not necessary in uncomplicated viral infections.

D. A client with significant respiratory symptoms: Clients showing significant respiratory distress, regardless of underlying cause, may benefit from an SVN to administer medications that relieve bronchospasm, decrease airway inflammation, and improve ventilation rapidly.

E. A client with mild seasonal allergies: Mild seasonal allergies usually present with sneezing, watery eyes, and nasal congestion without significant airway obstruction. SVNs are not indicated for mild allergic symptoms, as oral or intranasal antihistamines are sufficient.